William J. Magnuson

Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

William J. Magnuson, N.H. Lester-Coll, Abraham J. Wu et al. · Journal of Clinical Oncology · 2017 · 461 citations

Medicine, Oncology, Radiation Oncology +17

Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases

William J. Magnuson, Jacky T. Yeung, Paul Guillod et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 103 citations

Medicine, Oncology, Radiation Oncology +12

Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers

Zachary S. Morris, Sandeep Saha, William J. Magnuson et al. · Cancer · 2016 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab

William J. Magnuson, H. Ian Robins, Pranshu Mohindra et al. · Journal of Neuro-Oncology · 2014 · 41 citations

Medicine, Oncology, Radiation Oncology +12

Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases

N.H. Lester-Coll, Arie P. Dosoretz, William J. Magnuson et al. · Journal of neurosurgery · 2016 · 37 citations · Full text

Medicine, Oncology, Radiation Oncology +14